42 C.F.R. 413.234 - Drug designation process

Cite as42 C.F.R. 413.234
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
4 practice notes
1 cases
  • Department of Health and Human Services, B-330523
    • United States
    • Comptroller General of the United States
    • November 28, 2018
    ...rule on November 14, 2018. 83 Fed. Reg. 56, 922. The effective date of the final rule is January 1, 2019, except for amendments to 42 C.F.R. § 413.234, which are effective January 1, 2020. The final rule updates and makes revisions to the End-Stage Renal Disease (ESRD) Prospective Payment S......
3 provisions

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT